CTC releases second quarter results for the 2024/25 harvest

The Sugarcane Technology Center (CTC) reported positive financial results in the second quarter of the 2024/25 harvest (2Q25). Net revenue reached R$100,1 million, an increase of 12,3% compared to the same period of the previous harvest (2Q24). Net income was R$48,03 million, representing a growth of 22,7%.

Despite this, EBITDA registered a slight drop of 1,3%, with a margin of 42,1%. The company also ended the quarter with net cash of R$408,2 million, 24,5% higher than in 2Q24.

The performance was driven by the growth in the market share of genetically modified and elite sugarcane varieties, which increased from 26% to 30% of plantings. The expansion reflects the market's interest in solutions that combine advances in genetics and biotechnology for productivity gains.

Investments and strategic plans

CTC allocated R$54,1 million to research and development (R&D) in the quarter, 8,4% more than in 2Q24. Since 2012, the company has invested R$2 billion in innovation, including projects such as the Genetic Improvement program, the GM variety portfolio and the development of the Seeds project. CTC currently has 375 R&D professionals, including more than 200 masters and doctors, demonstrating the robustness of its technical team.

According to Paulo Geraldo Polezi, CFO and Investor Relations Director, the results demonstrate the market’s confidence in the company’s products. “We offer continuous productivity gains to sugarcane plantations, with new solutions in genetics, biotechnology and management,” said the executive.